Dureach

AnaCardio

Sweden
NameAddress
Solna, Stockholm, Sweden
https://anacardio.com

Company profile

AnaCardio company profile

AnaCardio is a clinical stage biopharmaceutical company developing novel drugs to treat heart failure.

Business identity

Website
https://anacardio.com
Operating status
Active
Company type
For Profit
Employee range
00011-00050 employees
Revenue range
$1K+
Founded
2017-01-01
LinkedIn

Headquarters

Headquarters
Solna, Stockholm, Sweden
Postal code
171 65
Country code
SE
Continent
Europe

Capital profile

Funding and company signals

Funding stage
Early Stage Venture
Funding rounds
4
Total equity funding
$32.4M
Last funding
Series A / $18.4M / 2025-01-09
Last equity funding
Series A / $18.4M
Investors
10
Lead investors
6
Articles
27

Categories and groups

BiopharmaBiotechnologyMedicalBiotechnologyHealth CareScience and Engineering

Founders and investors

Lead investors

Flerie InvestIndustrifondenKarolinskaNovo HoldingsPureos BioventuresSound Bioventures

Investors

IndustrifondenKarolinskaNovo HoldingsPureos BioventuresSound Bioventures

People at this company

Preview only. Contact details are available after you sign in.

Log in to view people and contact details at this company

Contact information and company affiliations may no longer be accurate. Verify details before reaching out.

Shipment data

Explore detailed shipment data

Sign in to view shipment history, products, suppliers, and trade lanes for this company.

Log in to view shipment data

Shipment records and coverage can change as the dataset is updated.